449 related articles for article (PubMed ID: 29231123)
1. Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.
George B; Joy MS; Aleksunes LM
Exp Biol Med (Maywood); 2018 Feb; 243(3):272-282. PubMed ID: 29231123
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin.
Ghadrdan E; Ebrahimpour S; Sadighi S; Chaibakhsh S; Jahangard-Rafsanjani Z
J Oncol Pharm Pract; 2020 Oct; 26(7):1643-1649. PubMed ID: 32046578
[TBL] [Abstract][Full Text] [Related]
3. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
Shinke H; Masuda S; Togashi Y; Ikemi Y; Ozawa A; Sato T; Kim YH; Mishima M; Ichimura T; Bonventre JV; Matsubara K
Cancer Chemother Pharmacol; 2015 Nov; 76(5):989-96. PubMed ID: 26407820
[TBL] [Abstract][Full Text] [Related]
4. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
[TBL] [Abstract][Full Text] [Related]
5. Urine Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 to Detect Pediatric Cisplatin-Associated Acute Kidney Injury.
McMahon KR; Chui H; Rassekh SR; Schultz KR; Blydt-Hansen TD; Mammen C; Pinsk M; Cuvelier GDE; Carleton BC; Tsuyuki RT; Ross CJD; Devarajan P; Huynh L; Yordanova M; Crépeau-Hubert F; Wang S; Cockovski V; Palijan A; Zappitelli M
Kidney360; 2022 Jan; 3(1):37-50. PubMed ID: 35368557
[TBL] [Abstract][Full Text] [Related]
6. Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin C.
Jelinek MJ; Lee SM; Wyche Okpareke A; Wing C; Koyner JL; Murray PT; Stadler WM; O' Donnell PH
Clin Transl Sci; 2018 Jul; 11(4):420-427. PubMed ID: 29691991
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patients.
Ibrahim ME; Chang C; Hu Y; Hogan SL; Mercke N; Gomez M; O'Bryant CL; Bowles DW; George B; Wen X; Buckley B; Aleksunes L; Joy MS
Eur J Clin Pharmacol; 2019 Jan; 75(1):51-57. PubMed ID: 30220072
[TBL] [Abstract][Full Text] [Related]
8. Urine ratio of neutrophil gelatinase-associated lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity.
Shahbazi F; Sadighi S; Dashti-Khavidaki S; Shahi F; Mirzania M
Iran J Kidney Dis; 2015 Jul; 9(4):306-10. PubMed ID: 26174458
[TBL] [Abstract][Full Text] [Related]
9. Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatin-induced acute kidney injury better than albuminuria or urinary cystatin C levels.
Lin HY; Lee SC; Lin SF; Hsiao HH; Liu YC; Yang WC; Hwang DY; Hung CC; Chen HC; Guh JY
Kaohsiung J Med Sci; 2013 Jun; 29(6):304-11. PubMed ID: 23684135
[TBL] [Abstract][Full Text] [Related]
10. Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical Nephrotoxicity.
George B; Wen X; Mercke N; Gomez M; O'Bryant C; Bowles DW; Hu Y; Hogan SL; Joy MS; Aleksunes LM
Clin Pharmacol Ther; 2017 Apr; 101(4):510-518. PubMed ID: 28002630
[TBL] [Abstract][Full Text] [Related]
11. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study.
Gaspari F; Cravedi P; Mandalà M; Perico N; de Leon FR; Stucchi N; Ferrari S; Labianca R; Remuzzi G; Ruggenenti P
Nephron Clin Pract; 2010; 115(2):c154-60. PubMed ID: 20407275
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
13. Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury.
Westhoff JH; Fichtner A; Waldherr S; Pagonas N; Seibert FS; Babel N; Tönshoff B; Bauer F; Westhoff TH
Pediatr Nephrol; 2016 Dec; 31(12):2353-2363. PubMed ID: 27286687
[TBL] [Abstract][Full Text] [Related]
14. Association of Urine Platinum With Acute Kidney Injury in Children Treated With Cisplatin for Cancer.
Lebel A; Chui H; McMahon KR; Lim YJ; Macri J; Wang S; Devarajan P; Blydt-Hansen TD; Zappitelli M; Urquhart BL
J Clin Pharmacol; 2021 Jul; 61(7):871-880. PubMed ID: 33599997
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.
Chang C; Hu Y; Hogan SL; Mercke N; Gomez M; O'Bryant C; Bowles DW; George B; Wen X; Aleksunes LM; Joy MS
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640195
[TBL] [Abstract][Full Text] [Related]
16. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
Shoji S; Hosojima M; Kabasawa H; Kondo R; Miura S; Watanabe S; Aoki N; Kaseda R; Kuwahara S; Tanabe N; Hirayama Y; Narita I; Kikuchi T; Kagamu H; Saito A
BMC Cancer; 2019 Dec; 19(1):1170. PubMed ID: 31791266
[TBL] [Abstract][Full Text] [Related]
17. Differences in Urinary Renal Failure Biomarkers in Cancer Patients Initially Treated with Cisplatin.
Maeda A; Ando H; Ura T; Muro K; Aoki M; Saito K; Kondo E; Takahashi S; Ito Y; Mizuno Y; Fujimura A
Anticancer Res; 2017 Sep; 37(9):5235-5239. PubMed ID: 28870959
[TBL] [Abstract][Full Text] [Related]
18. Urinary biomarkers may provide prognostic information for subclinical acute kidney injury after cardiac surgery.
Albert C; Albert A; Kube J; Bellomo R; Wettersten N; Kuppe H; Westphal S; Haase M; Haase-Fielitz A
J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2441-2452.e13. PubMed ID: 29366580
[TBL] [Abstract][Full Text] [Related]
19. Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.
Hosohata K; Ando H; Fujimura A
J Pharmacol Exp Ther; 2012 Jun; 341(3):656-62. PubMed ID: 22399813
[TBL] [Abstract][Full Text] [Related]
20. Does the kidney injury molecule-1 predict cisplatin-induced kidney injury in early stage?
Tekce BK; Uyeturk U; Tekce H; Uyeturk U; Aktas G; Akkaya A
Ann Clin Biochem; 2015 Jan; 52(Pt 1):88-94. PubMed ID: 24670880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
